Evidence map›Paper›PMID 27206859›Full record

ArticleJournal of cell science2016

TOR complex 2 localises to the cytokinetic actomyosin ring and controls the fidelity of cytokinesis.

Karen Baker, Sara Kirkham, Lenka Halova, Jane Atkin, Mirita Franz-Wachtel, David Cobley, Karsten Krug, Boris Maček, Daniel P Mulvihill, Janni Petersen

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Karen BakerSchool of Biosciences, University of Kent, Giles Lane, Canterbury, Kent CT2 7NJ, UK.
Sara KirkhamFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Lenka HalovaFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Jane AtkinFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Mirita Franz-WachtelProteome Center Tübingen, Auf der Morgenstelle 15, Tübingen 72076, Germany.
David CobleyFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Karsten KrugProteome Center Tübingen, Auf der Morgenstelle 15, Tübingen 72076, Germany.
Boris MačekProteome Center Tübingen, Auf der Morgenstelle 15, Tübingen 72076, Germany.
Daniel P MulvihillSchool of Biosciences, University of Kent, Giles Lane, Canterbury, Kent CT2 7NJ, UK d.p.mulvihill@kent.ac.uk Janni.Petersen@Flinders.edu.au.ORCID 0000-0003-2502-5274
Janni PetersenFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University, Adelaide, SA 5001, Australia South Australia Health and Medical Research Institute, North Terrace, PO Box 11060, Adelaide, SA 5000, Australia d.p.mulvihill@kent.ac.uk Janni.Petersen@Flinders.edu.au.
University of Manchester · GBUniversity of Kent · GBFlinders University · AU

Funding

Biotechnology and Biological Sciences Research CouncilCancer Research UKWellcome Trust
6 · The paper itself

Abstract

The timing of cell division is controlled by the coupled regulation of growth and division. The target of rapamycin (TOR) signalling network synchronises these processes with the environmental setting. Here, we describe a novel interaction of the fission yeast TOR complex 2 (TORC2) with the cytokinetic actomyosin ring (CAR), and a novel role for TORC2 in regulating the timing and fidelity of cytokinesis. Disruption of TORC2 or its localisation results in defects in CAR morphology and constriction. We provide evidence that the myosin II protein Myp2 and the myosin V protein Myo51 play roles in recruiting TORC2 to the CAR. We show that Myp2 and TORC2 are co-dependent upon each other for their normal localisation to the cytokinetic machinery. We go on to show that TORC2-dependent phosphorylation of actin-capping protein 1 (Acp1, a known regulator of cytokinesis) controls CAR stability, modulates Acp1-Acp2 (the equivalent of the mammalian CAPZA-CAPZB) heterodimer formation and is essential for survival upon stress. Thus, TORC2 localisation to the CAR, and TORC2-dependent Acp1 phosphorylation contributes to timely control and the fidelity of cytokinesis and cell division.

Indexed as

Actin Capping ProteinsActinsActomyosinCell DivisionCytokinesisMechanistic Target of Rapamycin Complex 2Multiprotein ComplexesMyosin Heavy ChainsMyosinsPhosphorylationSchizosaccharomycesSchizosaccharomyces pombe ProteinsTOR Serine-Threonine KinasesActin Capping ProteinsActinsActomyosinMechanistic Target of Rapamycin Complex 2Multiprotein ComplexesMyo51 protein, S pombeMyosin Heavy ChainsMyosinsMyp2 protein, S pombeSchizosaccharomyces pombe ProteinsTOR Serine-Threonine KinasesAcp1CAPZAMyosin IIMyosin VRictorSchizosaccharomyces pombeTORTORC2

Identifiers

PMID27206859
PMCPMC4958305
OpenAlexW2402864185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.